|
Market Closed -
NYSE
16:00:03 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 12.45 USD | +0.48% |
|
+9.69% | -22.33% |
| 07-30 | Core Laboratories Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-29 | Core Laboratories Inc. Provides Earnings Guidance for the Third Quarter of 2026 | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 30x | - | -0.77x | - | - | - | 0.32% | 571M | ||
| 25.44x | 13.79x | 3.49x | 2.85x | 12.83x | 17.73x | 3.38% | 22.99B | ||
| 27.86x | 8.76x | 0.38x | 4.84x | 17.76x | 24.12x | 0.75% | 15.64B | ||
| 20.07x | 2.73x | 1.37x | 2.87x | 11.82x | 16.88x | 1.32% | 3.47B | ||
| -35.4x | 1.02x | 0.66x | 1.53x | 9.88x | 43.03x | -.--% | 2.16B | ||
| 12.25x | 1.61x | 1.85x | - | - | - | 2.67% | 2.06B | ||
| 22.08x | 2.77x | 4.94x | - | - | - | 2.31% | 1.6B | ||
| 34x | 1.99x | 2.44x | - | - | - | - | 648M | ||
| 18.22x | 2.85x | -24.43x | - | - | - | - | 618M | ||
| 37.05x | 1.38x | -0.26x | - | - | - | - | 600M | ||
| Average | 19.16x | 4.10x | -1.03x | 3.02x | 13.07x | 25.44x | 1.53% | 5.03B | |
| Weighted average by Cap. | 22.78x | 9.59x | 1.79x | 3.49x | 14.35x | 21.16x | 2.13% |
- Stock Market
- Stocks
- CLB Stock
- Sector Core Laboratories Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















